Interventional Neuro Associates

What Interventional Neuro Associates does

Interventional Neuro Associates (INA) is a physician-owned interventional neurology private practice founded in 2011 by Dr. Jeffrey Farkas and headquartered in Brooklyn, NY. The practice specializes in minimally invasive, catheter-based neurointerventional procedures, with a core focus on acute stroke management via mechanical thrombectomy and a broader portfolio spanning aneurysm treatment (coil embolization, stent-assisted coiling, pipeline embolization, WEB embolization), carotid and intracranial stenting, venous sinus stenting, middle meningeal artery embolization, and diagnostic cerebral angiography. Services are delivered by a team of approximately 10 clinicians (eight neurologists, one radiologist, plus nurse practitioners and physician assistants) fellowship-trained at top institutions including Massachusetts General Hospital, NYU Langone, University of Toronto, Mount Sinai, and Albert Einstein/Montefiore.

INA operates a hub-and-spoke delivery model anchored by four patient-facing offices in Brooklyn, East Hills (Long Island), Rutherford, and Denville, with procedural coverage extended across 10 partner hospitals spanning New York City, Long Island, Staten Island, and multiple New Jersey counties. The practice provides 24/7 emergency stroke call coverage to these hospitals, which include NYU Langone-Brooklyn, Hackensack University Medical Center, Richmond University Medical Center, St. Francis Hospital, Winthrop University Hospital, and several Prime Healthcare-affiliated sites in New Jersey. Patients are referred primarily through hospital emergency departments for acute stroke and other neurovascular emergencies, as well as through elective channels for aneurysm, carotid, and venous sinus conditions.

Revenue is generated on a fee-for-service professional billing basis, with services covered by Medicare, Medicaid, and a broad panel of commercial payers including Cigna, Aetna, Anthem Blue Cross, United Healthcare, Emblem Health, Empire, Horizon, 1199, and NALC plans. INA also operates a neurointerventional fellowship training program under Dr. Farkas and maintains collaborative relationships with medical device manufacturers, supporting early access to advanced embolization and stenting technologies. The practice is privately held with no disclosed outside investment, and its growth has been entirely organic since inception.

Name

Interventional Neuro Associates

Legal name

Interventional Neuro Associates

Website

https://intneuro.org

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Interventional Neuro Associates is a physician-owned interventional neurology practice delivering 24/7 mechanical thrombectomy, aneurysm, and neurovascular care across 10 hospitals in New York and New Jersey, supported by four patient offices and a fellowship-trained specialist team.

Ownership category

akta.pro rank

Product category

Interventional Neurology / Neurovascular Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Stroke & Vascular Neurology (HLAKAIAG)

akta.pro secondary industries

Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD), Neurocritical Care (HLAKAIAI)

Keywords

• Interventional neurology
• Stroke thrombectomy
• Endovascular neurosurgery
• Cerebral aneurysm treatment
• Neurovascular procedures

Headquarters

HQ city

Brooklyn

HQ country

United States

HQ region

North America

Offices15 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Medical Services Revenue: Fee-for-service medical practice revenue from providing neurointerventional procedures, stroke care, and related medical services to hospital patients. Services billed through insurance including Medicare/Medicaid and private payers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Interventional Neuro Associates is a physician-owned interventional neurology practice that delivers minimally invasive, catheter-based neurointerventional procedures including mechanical thrombectomy, cerebral angiography, aneurysm embolization, carotid stenting, intracranial stenting, venous sinus stenting, and middle meningeal artery embolization. Services are provided 24/7 at ten partner hospitals across New York and New Jersey, treating patients with acute ischemic stroke, brain aneurysms, carotid stenosis, and other neurovascular conditions.

Product overview

Interventional Neuro Associates is a physician-owned interventional neurology practice offering a comprehensive suite of neurovascular treatment procedures. The core service portfolio includes diagnostic cerebral angiography and a range of minimally invasive treatment procedures: mechanical thrombectomy for acute ischemic stroke, various aneurysm treatments (coil embolization, stent-assisted coil embolization, pipeline embolization, WEB embolization), carotid stenting, intracranial arterial stenting, venous sinus stenting, MMA embolization for subdural hematomas, and epistaxis embolization. These procedures are delivered by board-certified specialists across ten hospitals in New York and New Jersey, with 24/7 emergency stroke care capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Cerebral Angiogram A minimally invasive diagnostic procedure using X-ray dye and catheter insertion through the femoral arteries to image blood flow in the brain and detect aneurysms, hemorrhages, clots, and other vascular issues.
• Thrombectomy A minimally invasive emergency procedure in which a catheter is inserted through the femoral arteries and guided to the brain to remove blood clots causing blockages and restore normal arterial blood flow for acute ischemic stroke patients.
• Minimally Invasive Brain Aneurysm Treatment Catheter-based minimally invasive treatment options for brain aneurysms aimed at improving blood flow and preventing rupture or growth, encompassing coil, stent-assisted, pipeline, and WEB embolization techniques.
• Carotid Stent Placement of a metal stent inside the carotid artery to open the artery and restore blood flow to the brain, helping to prevent future strokes in patients with carotid artery stenosis.
• Coil Embolization A catheter-based procedure where metallic coils are inserted into an aneurysm to promote blood clotting, seal off the aneurysm, and prevent rupture or growth.
• Stent-Assisted Coil Embolization A variation of coil embolization using a mesh stent as a scaffold to hold coils in place within wide-necked or irregularly shaped aneurysms.
• Pipeline Embolization An advanced flow-diverting stent procedure effective for complex aneurysms that are difficult to treat with coiling or clipping, including previously coiled aneurysms.
• WEB Embolization (W.E.B.) First-in-class intrasaccular technology offering a single-device treatment alternative to endovascular coils and complex stenting procedures, minimizing the need for dual antiplatelet therapy.
• Middle Meningeal Artery (MMA) Embolization

Quantifiable outcome

• Over 1000 procedures performed
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Twelve partnerships are on record, tiered core.

• Richmond University Medical CentercoreStrategic or Co-development PartnerServing as neurointerventional stroke care provider at Richmond University Medical Center in Staten Island, NY, providing 24/7 emergency stroke coverage and mechanical thrombectomy services
• St. Francis HospitalcoreStrategic or Co-development PartnerProviding neurointerventional services at St. Francis Hospital on Long Island for stroke and endovascular care
• NYU Langone Hospital - BrooklyncoreStrategic or Co-development PartnerStroke care team at NYU Langone Brooklyn, featured in patient success stories and media coverage for advanced stroke treatment outcomes
• Brookdale HospitalcoreStrategic or Co-development PartnerNeurointerventional coverage at Brookdale Hospital in Brooklyn, NY for stroke and vascular neurology services
• Hackensack University Medical Center (HUMC)coreStrategic or Co-development PartnerProviding neurointerventional stroke care services at HUMC in New Jersey
• Christ HospitalcoreStrategic or Co-development PartnerNeurointerventional services including stroke treatment and endovascular procedures
• Bayonne HospitalcoreStrategic or Co-development PartnerStroke care and neurointerventional services in Bayonne, NJ
• Hoboken University Medical CentercoreStrategic or Co-development PartnerEmergency stroke coverage and thrombectomy services at Hoboken hospital location
• St. Michael's Medical CentercoreStrategic or Co-development PartnerNeurointerventional stroke care services at St. Michael's Medical Center in Newark, NJ
• St. Clare's Health SystemcoreStrategic or Co-development PartnerStroke care coverage at St. Clare's Denville Hospital in New Jersey
• St. Mary's General HospitalcoreStrategic or Co-development PartnerNeurointerventional services including emergency stroke treatment at St. Mary's General Hospital in Passaic, NJ
• Winthrop University HospitalcoreStrategic or Co-development PartnerNeurointerventional and stroke care services at Winthrop Hospital in Mineola, NY

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Tenet Healthcare: Large national hospital operator with significant neuro and stroke service lines across multiple states. Operates competing stroke programs that could affect INA's hospital contracts and partner dynamics at shared geographies.
• Northwell Health Neurosurgery: Large New York-area health system with comprehensive neurointerventional and stroke programs. Competes for the same hospital-based neurointerventional coverage market in NY and represents the in-house employment alternative to INA's private practice model.
• Mount Sinai Health System: Major New York academic medical center with comprehensive neurointerventional services and fellowship programs. Several INA physicians trained at Mount Sinai fellowships, and the system competes for both patients and neurointerventional coverage contracts in NY.
• NYU Langone Health: Major New York academic medical system; INA currently provides stroke coverage at NYU Langone Hospital-Brooklyn. Represents both a partner and a potential in-house competitor if NYU expands employed neurointerventional physician ranks.
• Hackensack Meridian Health: Large New Jersey hospital system with neurointerventional capabilities at Hackensack University Medical Center, one of INA's key hospital partners. Represents a significant customer and a potential future in-house competitor for neurointerventional coverage.

Regional players

• Capital Health Neurointerventional Surgery: Regional health system-based neurointerventional program in New Jersey providing thrombectomy and stroke care. Comparable specialty services and shared NJ market, though hospital-employed rather than independent practice.
• Atlantic NeuroSurgical Specialists: Physician-owned neurosurgery and neurointerventional group serving New Jersey, overlapping with INA's NJ footprint. Comparable specialty services, similar private-practice structure, and direct geographic overlap in the Bergen/Morris County areas.

Direct peers

• Goodman Campbell Brain and Spine: Physician-owned private neurosurgery and neurointerventional practice in Indianapolis with fellowship-trained specialists covering multiple hospital systems. Closely comparable to INA in structure, subspecialty focus, and hospital-based service delivery.
• Semmes-Murphey Clinic: Large private physician-owned neurosurgery and neurointerventional practice based in Memphis, TN. Operates as an independent specialty group providing endovascular and surgical neuro care across multiple hospital partners, directly analogous to INA's business model.

Others

• Medtronic Neurovascular: Major manufacturer of thrombectomy, embolization, and neurovascular devices used in INA's procedures. Functions as an enabling technology supplier and industry collaborator rather than a clinical competitor, but influences procedural economics and adoption of new techniques.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/InterventionalNeuroAssociatesLLC
• LinkedInlinkedin.com/company/interventional-neuro-associates

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Interventional Neuro Associates